The Patient in the Middle Point
A turning point in oncology and the development of cancer medications is unfolding and Dr. Jean Cui is in the forefront of unprecedented changes. She explains that
the patient now occupies a central role in development from the very beginning and drug development teams have evolved to
agile collaborations that work toward a narrower goal. What challenges will cancer drug development face in the future?
Discover Dr. Cui’s answers to this and other questions. (PDF, 421kb)